Treatment of streptozotocin-induced diabetic rats with vanadate and phlorizin prevents the over-expression of the liver insulin receptor gene

European Journal of Endocrinology

Volumn 140, Issue 1, 1999, Pages 79-86

  Amessou, M ^a   Bortoli, S ^a   Liemans, V ^a   Collinet, M ^a   Desbuquois, B ^a   Brichard, S ^b,c   Girard, J ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Ceremod   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; MESSENGER RNA; PHLORIZIN; STREPTOZOCIN; VANADIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEPATOMA CELL; INSULIN BINDING; INSULIN BLOOD LEVEL; LIVER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; ERRATUM; ERROR;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; INSULIN; LIVER; MALE; PHLORHIZIN; RATS; RATS, WISTAR; RECEPTOR, INSULIN; RNA, MESSENGER; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED; VANADATES;

EID: 0033049220     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400079     Document Type: Article

References (36)

1. Shechter Y. Insulin-mimetic effects of vanadate. Possible implications for the future treatment of diabetes. Diabetes 1990 39 1-5.
2. Brichard SM & Henquin JC. The role of vanadium in the management of diabetes. Trends Pharmacological Sciences 1995 16 265-270.
3. Tsiani E & Fantus IG. Vanadium compounds. Biological actions and potential as pharmacological agents. Trends in Endocrinology and Metabolism 1997 8 51-58.
4. Gil J, Miralpeix M, Carrerasq J & Bartrons R. Insulin-like effects of vanadate on glucokinase activity and fructose 2.6-biphosphate levels in the liver of diabetic rats. Journal of Biological Chemistry 1988 263 1868-1871.
5. Pugazhenthi S & Khandelwal RL. Insulin-like effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozotocin-induced diabetic rats. Diabetes 1990 39 821-827.
6. Miralpeix M, Carballo E, Bartrons R, Crepin K, Hue L & Rousseau GG. Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA. Diabetologia 1992 35 243-248.
7. Valera A, Rodriguez-Gil JE & Bosch F. Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats. Journal of Clinical Investigation 1993 92 4-11.
8. Brichard SM, Desbuquois B & Girard J. Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT 2. Molecular unit Cellular Endocrinology 1993 91 91-97.
9. Brichard SM, Ongemba LN, Girard J & Henquin JC. Tissue-specific correction of lipogenic enzymes expression in diabetic rats given vanadate. Diabetologia 1994 37 1065-1072.
10. Barrera-Hernandez G, Wanke I & Wong NCW. Phlorizin or vanadate treatment reverses impaired expression of albumin and hepatocyte nuclear factor 1 in diabetic rats. Diabetes 1996 45 1217-1222.
11. Bosch F, Sabater J & Valera A. Insulin inhibits liver expression of the CCAAT/enhancer-binding protein β. Diabetes 1995 44 267-271.
12. Brichard SM, Henquin JC & Girard J. Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism. Diabetologia 1993 36 292-298.
13. Rossetti L, Smith D, Shulman GL, Papachristou D & De Fronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. Journal of Clinical Investigation 1987 79 1510-1515.
14. Miralpeix M, Decaux JF, Kahn A & Bartrons R. Vanadate induction of L-type pyruvate kinase mRNA in adult rat hepatocytes in primary culture. Diabetes 1991 40 462-465.
15. Bosch F, Hatzoglou M, Park EA & Hanson RW. Vanadate inhibits expression of the gene for phosphoenolpyruvate carboxykinase (GTP) in rat hepatoma cells. Journal of Biological Chemistry 1990 265 13677-13682.
16. Davidson MB & Kaplan SA. Increased insulin binding by hepatic plasma membranes from diabetic rats. Normalization by insulin therapy. Journal at Clinical Investigation 1977 59 22-30.
17. Okamoto M, White MF, Maron R & Kahn CR. Autophosphorylation and kinase activity of insulin receptor in diabetic rats. American Journal of Physiology 1986 251 E542-E550.
18. Lopez S, Burlet H & Desbuquois B. Mechanisms of up-regulation of the liver insulin receptor in chronically hypoinsulinemic rats: assessment of receptor endocytosis. Molecular and Cellular Endocrinohgy 1991 82 159-164.
19. Tozzo E & Desbuquois B. Effects of STZ-induced diabetes and fasting on insulin receptor mRNA expression and insulin receptor gene transcription in rat liver. Diabetes 1992 41 1609-1616.
20. Secchi LA, Griffin CA, Grady E, Grunfeld C, Kalinyak JE & Schambelan M. Tissue-specific regulation of insulin receptor mRNA in rats with STZ-induced diabetes mellitus. Diabetes 1992 41 1113-1118.
21. Vidal H, Auboeuf D, Beylot M & Riou JP. Regulation of insulin receptor mRNA splicing in rat tissues. Effect of fasting, aging and diabetes. Diabetes 1995 44 1196-1201.
22. Meyerovitch J, Farfel Z, Sack J & Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. Journal of Biological Chemistry 1987 262 6658-6662.
23. Venkatesan N, Avidan A & Davidson MB. Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity. Diabetes 1991 40 492-498.
24. Fantus IG, Armad F & Deragon G. Vanadate augments insulin binding and prolongs insulin action in rat adipocytes. Endocrinology 1990 127 2716-2725.
25. Marshall S, Garvey WT & Monzon R. Shunting of insulin from a retroendocytotic pathway to a degradative pathway by sodium vanadate. Journal of Biological Chemistry 1987 262 12005-12012.
26. Marshall S & Monzon R, Down-regulation of cell surface insulin receptors in primary cultured rat adipocytes by sodium vanadate. Endocrinology 1987 121 1116-1122.
27. Torossian K, Freedman D & Fantus IG. Vanadate down-regulates cell surface insulin and growth hormone receptors and inhibits insulin receptor degradation in cultured human lymphocytes. Journal of Biological Chemistry 1988 263 9353-9359.
28. Bortoli S, Amessou M, Collinet M, Desbuquois B & Lopez S. Vanadate, but not insulin, inhibits insulin receptor gene expression in rat hepatoma cells. Endocrinology 1997 138 4821-4829.
29. Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 156-159.
30. Deschatrette J & Weiss MC. Characterization of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie 1974 56 1603-1611.
31. Chandramouli V & Carter JR. Cell membrane changes in chronically diabetic rats. Diabetes 1975 24 257-262.
32. Mrejen C, Hauguel-de-Mouzon S, Cauzac M & Girard J. Regulation of hepatic insulin receptor mRNA expression by acute and chronic hyperglycemia in pregnant rats. Endocrinology and Metabolism 1996 3 125-133.
33. Ludwig S, Muller-Wieland D, Goldstein B & Kahn CR. The insulin receptor gene and its expression in insulin-resistant mice. Endocrinology 1989 123 594-600.
34. Briata P, Gherzi R, Adezati L & Cordera L. Effect of two different glucose concentrations on insulin receptor mRNA levels in human hepatoma HepG2 cells. Biochemical and Biophysical Research Communications 1989 160 1415-1420.
35. Hauguel-de Mouzon S, Mrejen C, Alengrin F & Van Obberghen E. Glucose-induced stimulation of human insulin-receptor mRNA and tyrosine kinase activity in cultured cells. Biochemical Journal 1995 305 119-124.
36. Huang Z, Bodkin NL, Ortmeyer HK, Hansen BC & Shuldiner AR. Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey. Journal of Clinical Investigation 1994 94 1289-1296.